PROVIDER PROFILE · NPI 1043749765
Gino ChesiniDO
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,642
Unique beneficiaries
—
Total services
56,709
Distinct HCPCS
53
Medicare payment
$595K
Peer benchmark
Total Medicare services vs. 39 Rheumatology providers in IA — above median (cohort median 67,274).
PRESCRIBING · PART D · 2024
Total Rx claims
1,662
Beneficiaries
—
Total drug cost
$641K
Distinct drugs
30
Brand share
30.6%
Top prescribed drugs
Methotrexate Sodium279 claims
Prednisone264 claims
Hydroxychloroquine Sulfate227 claims
Hydrocodone/Acetaminophen124 claims
Alendronate Sodium115 claims
QUALITY · MIPS · 2024
Final MIPS score
76.9
Quality
82.5
Cost
52.0
Improvement activities
40.0
Promoting interop.
86.0
Payment adjustment
0.08%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CROSS-REFERENCE